PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus

Author：              

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.4, 2014-01, pp. : 1581-1588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation

By Imai Yasuo   Yoshimori Mayumi   Fukuda Kazunori   Yamagishi Hidetsugu   Ueda Yoshihiko  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 1703-1709

Spandidos Publications

Access to resources Recommend Favorite

LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 575-579

Spandidos Publications

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite

Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells

By          

International Journal of Oncology, Vol. 43, Iss. 2, 2013-01 ,pp. : 600-610

Spandidos Publications

Access to resources Recommend Favorite

12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway

By            

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1755-1760

Spandidos Publications

Access to resources Recommend Favorite